No Response to First-Line Tenofovir plus Lamivudine plus Efavirenz Despite Optimization According to Baseline Resistance Testing: Impact of Resistant Minority Variants on Efficacy of Low Genetic Barrier Drugs

AuthID
 P-00F-T0E
7
Author(s)
Verbesselt, R
·
Van Ranst, M
·
Van Wijngaerden, E
·
Document Type
Article
Year published
2007
Published
in JOURNAL OF CLINICAL VIROLOGY, ISSN: 1386-6532
Volume: 39, Issue: 1, Pages: 43-47 (5)
Indexing
Wos®
Scopus®
Crossref®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 17369083
SCOPUS: 2-s2.0-34147118573
Wos: WOS:000248631300007
Source Identifiers
ISSN: 1386-6532
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service